TFGT
IBB icon

TS Financial Group (TSFG)’s iShares Biotechnology ETF IBB Stock Holding History

TS Financial Group (TSFG)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Hold
182
– – ﹤0.01% 427
2026
Q1 		$31K Hold
182
– – ﹤0.01% 409
2025
Q4 		$31K Hold
182
– – ﹤0.01% 416
2025
Q3 		$26K Sell
182
-150
-45% -$20.5K ﹤0.01% 437
2025
Q2 		$42K Hold
332
– – 0.01% 358
2025
Q1 		$42K Sell
332
-140
-30% -$19K 0.01% 341
2024
Q4 		$62K Sell
472
-658
-58% -$92.5K 0.01% 267
2024
Q3 		$164K Hold
1,130
– – 0.04% 162
2024
Q2 		$155K Hold
1,130
– – 0.04% 160
2024
Q1 		$155K Sell
1,130
-1,434
-56% -$196K 0.04% 163
2023
Q4 		$348K Sell
2,564
-4,909
-66% -$599K 0.11% 107
2023
Q3 		$914K Sell
7,473
-952
-11% -$121K 0.33% 60
2023
Q2 		$1.07M Sell
8,425
-1,659
-16% -$216K 0.4% 54
2023
Q1 		$1.3M Sell
10,084
-164
-2% -$21.5K 0.48% 44
2022
Q4 		$1.34M Sell
10,248
-20
-0.2% -$2.58K 0.53% 41
2022
Q3 		$1.2M Sell
10,268
-52
-0.5% -$6.46K 0.56% 34
2022
Q2 		$1.21M Sell
10,320
-451
-4% -$53.5K 0.52% 36
2022
Q1 		$1.4M Buy
10,771
+457
+4% +$59.5K 0.51% 33
2021
Q4 		$1.57M Buy
10,314
+170
+2% +$26.3K 0.55% 32
2021
Q3 		$1.64M Buy
10,144
+741
+8% +$125K 0.64% 31
2021
Q2 		$1.54M Buy
9,403
+5,862
+166% +$903K 0.62% 32
2021
Q1 		$533K Buy
3,541
+1
+0% +$159 0.27% 50
2020
Q4 		$536K Buy
3,540
+254
+8% +$36.3K 0.29% 47
2020
Q3 		$445K Buy
3,286
+277
+9% +$37.6K 0.26% 51
2020
Q2 		$411K Buy
3,009
+351
+13% +$44.7K 0.27% 53
2020
Q1 		$286K Buy
2,658
+174
+7% +$20K 0.26% 60
2019
Q4 		$299K Sell
2,484
-84
-3% -$9.37K 0.22% 67
2019
Q3 		$255K Sell
2,568
-191
-7% -$20K 0.2% 71
2019
Q2 		$301K Sell
2,759
-242
-8% -$25.7K 0.24% 62
2019
Q1 		$335K Buy
+3,001
New +$329K 0.29% 59

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

TS Financial Group (TSFG)'s IBB Position: Q2 2026 in Review

TS Financial Group (TSFG) held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 182 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

TS Financial Group (TSFG) first reported a position in IBB in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.64M in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • TS Financial Group (TSFG) held 182 shares of iShares Biotechnology ETF worth $35K as of Q2 2026.
  • TS Financial Group (TSFG) left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #427 holding.
  • TS Financial Group (TSFG) first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 30 quarters since.
  • TS Financial Group (TSFG)'s iShares Biotechnology ETF position peaked at $1.64M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.